- Home
- CDXS vs SCPH Comparison
CDXS vs SCPH Comparison
Compare CDXS & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- SCPH
- Stock Information
- Founded
- CDXS 2002
- SCPH 2013
- Country
- CDXS United States
- SCPH United States
- Employees
- CDXS N/A
- SCPH N/A
- Industry
- CDXS Major Chemicals
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- CDXS Industrials
- SCPH Health Care
- Exchange
- CDXS Nasdaq
- SCPH Nasdaq
- Market Cap
- CDXS 332.0M
- SCPH 274.7M
- IPO Year
- CDXS 2010
- SCPH 2017
- Fundamental
- Price
- CDXS $5.28
- SCPH $3.26
- Analyst Decision
- CDXS Buy
- SCPH Strong Buy
- Analyst Count
- CDXS 2
- SCPH 2
- Target Price
- CDXS $11.00
- SCPH $15.00
- AVG Volume (30 Days)
- CDXS 875.4K
- SCPH 544.0K
- Earning Date
- CDXS 10-31-2024
- SCPH 11-13-2024
- Dividend Yield
- CDXS N/A
- SCPH N/A
- EPS Growth
- CDXS N/A
- SCPH N/A
- EPS
- CDXS N/A
- SCPH N/A
- Revenue
- CDXS $64,446,000.00
- SCPH $30,278,000.00
- Revenue This Year
- CDXS N/A
- SCPH $174.12
- Revenue Next Year
- CDXS $2.02
- SCPH $133.41
- P/E Ratio
- CDXS N/A
- SCPH N/A
- Revenue Growth
- CDXS N/A
- SCPH 303.87
- 52 Week Low
- CDXS $2.53
- SCPH $3.08
- 52 Week High
- CDXS $6.08
- SCPH $6.71
- Technical
- Relative Strength Index (RSI)
- CDXS 59.97
- SCPH 43.13
- Support Level
- CDXS $5.42
- SCPH $3.11
- Resistance Level
- CDXS $6.01
- SCPH $3.67
- Average True Range (ATR)
- CDXS 0.39
- SCPH 0.21
- MACD
- CDXS -0.05
- SCPH 0.01
- Stochastic Oscillator
- CDXS 46.67
- SCPH 31.54
About CDXS Codexis Inc.
Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products, leveraging its proprietary CodeEvolver directed evolution technology platform. The firm's products and services include Biocatalysts and Enzymes. The company generates majority of its revenue through product sales and also licenses its technology platform CodeEvolver to pharmaceutical companies enabling them to use this technology, in-house, to engineer enzymes for their own businesses. Geographically, it derives revenue from the United States, Ireland, Switzerland, China and other markets.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.